Live Breaking News & Updates on Arrowhead Pharmaceuticals Inc

Stay updated with breaking news from Arrowhead pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HC Wainwright Reiterates "Buy" Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report released on Monday, Benzinga reports. They currently have a $90.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Arrowhead Pharmaceuticals’ FY2028 earnings at $0.43 EPS. A number of other equities analysts […] ....

United States , Hongbo Lu , Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Price Performance , Securities Exchange Commission , Canada Life Assurance , Arrowhead Pharmaceuticals Inc , Institutional Trading Of Arrowhead Pharmaceuticals , Pricet Rowe Associates Inc , Avoro Capital Advisors , Insider Transactions At Arrowhead Pharmaceuticals , Morgan Stanley , News Ratings For Arrowhead Pharmaceuticals Daily , Analyst Recommendations For Arrowhead Pharmaceuticals , Royal Bank , Affinity Asset Advisors , Free Report , Arrowhead Pharmaceutical , Chardan Capital , Moderate Buy , Get Free Report , Director Victoria Vakiener , Exchange Commission , Capital Advisors , Asset Advisors , Arrowhead Pharmaceuticals Daily ,

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 7.4%

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 7.4%
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Hudson Bay , Hongbo Lu , Morgan Stanley , Arrowhead Pharmaceuticals Stock , Citigroup Inc , Arrowhead Pharmaceuticals , Royal Bank , Invesco Ltd , Institutional Trading Of Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Inc , News Ratings For Arrowhead Pharmaceuticals Daily , Get Free Report , Director Victoria Vakiener , Hudson Bay Capital Management , Bay Capital Management , Arrowhead Pharmaceuticals Daily ,

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target Lowered to $27.00 at Morgan Stanley

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target Lowered to $27.00 at Morgan Stanley
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Hudson Bay , United States , Kenneth Allen Myszkowski , Morgan Stanley , Arrowhead Pharmaceuticals Stock Performance , Arrowhead Pharmaceuticals Inc , Institutional Trading Of Arrowhead Pharmaceuticals , Insider Transactions At Arrowhead Pharmaceuticals , Analyst Recommendations For Arrowhead Pharmaceuticals , News Ratings For Arrowhead Pharmaceuticals Daily , Arrowhead Pharmaceuticals , Securities Exchange Commission , Royal Bank , Invesco Ltd , Citigroup Inc , Free Report , Moderate Buy , Get Free Report , Allen Myszkowski , Exchange Commission , Director Victoria Vakiener , Hudson Bay Capital Management , Bay Capital Management , Arrowhead Pharmaceuticals Daily ,

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Rating of "Moderate Buy" from Analysts

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Rating of "Moderate Buy" from Analysts
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Hudson Bay , Hongbo Lu , Kenneth Allen Myszkowski , Invesco Ltd , Institutional Trading Of Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Inc , Royal Bank , Arrowhead Pharmaceuticals , News Ratings For Arrowhead Pharmaceuticals Daily , Securities Exchange Commission , Analyst Recommendations For Arrowhead Pharmaceuticals , Morgan Stanley , Arrowhead Pharmaceuticals Stock Performance , Citigroup Inc , Get Free Report , Allen Myszkowski , Exchange Commission , Hudson Bay Capital Management , Bay Capital Management , Get Free , Arrowhead Pharmaceuticals Daily ,

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Estimates By $0.96 EPS

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Estimates By $0.96 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Kenneth Allen Myszkowski , Arrowhead Pharmaceuticals Inc , Securities Exchange Commission , Earnings History For Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Company Profile , Royal Bank , News Ratings For Arrowhead Pharmaceuticals Daily , Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Price Performance , Morgan Stanley , Get Free Report , Director Victoria Vakiener , Allen Myszkowski , Exchange Commission , Arrowhead Pharmaceuticals Daily ,